Kristin Baldea, MD
Urology · Maywood, ILNPI 1265660393
Payments from drug & device makers
Across 45 payments — averaging $173.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$5K
- Boston Scientific$2K
- Procept Biorobotics Corporation$573
- Cook Medical LLC$561
- Olympus America Inc.$138
- Valencia Technologies Corporation$20
- plus $4 from 1 others
What the payments were for
- Consulting fees$5,00064%
- Food & beverage$2,80236%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 1 | $5,000 |
| Boston Scientific | 33 | $1,505 |
| Procept Biorobotics Corporation | 4 | $573 |
| Cook Medical LLC | 4 | $561 |
| Olympus America Inc. | 1 | $138 |
| Valencia Technologies Corporation | 1 | $20 |
| Intuitive Surgical | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AquaBeam Robotic System$429
- LITHO 150$330
- LithoVue$265
- Cook$148
- AQUABEAM SYSTEM$145
- iTIND System$138
- AMS$125
How this compares
$7,802 in reported general payments places this provider in the 75th percentile of 550 urology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 78 | $39,099 |
| GemtesaVibegron | 16 | $8,785 |
| Potassium Citrate ErPotassium Citrate | 64 | $6,710 |
| Trospium Chloride | 41 | $2,160 |
| Estradiol | 32 | $1,520 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 56 | $1,409 |
| Methenamine Hippurate | 14 | $1,172 |
| Tamsulosin Hcl | 90 | $916 |
| Finasteride | 56 | $825 |
| Oxybutynin Chloride ErOxybutynin Chloride | 27 | $426 |
| Trimethoprim | 13 | $303 |
| Cephalexin | 32 | $221 |
| Chlorthalidone | 18 | $153 |
| Levofloxacin | 17 | $87 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $76 |
Paid to pharmacies, not to this prescriber.
Other urology in Maywood
- Marcus QuekMaywood$70K
- Olivia CopelanMaywood$55K
- Mark BrandtPark Ridge$3M
- Ashley RossChicago$2.3M
- Aaron BergerChicago Ridge$2.1M
- Joshua MeeksChicago$2M
- Courtney HollowellChicago$1.9M
- David LieberSpringfield$1.5M
- Gary SteinbergChicago$1.4M
- Brian HelfandChicago$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.